2026-04-30 03:21:05
This article provides a detailed overview of elafibranor's mechanism of action in cholestatic liver diseases such as primary biliary cholangitis (PBC), analyzes its efficacy maintenance characteristics during long-term treatment, clarifies the applicable boundaries of the "drug resistance" concept, and explains key clinical monitoring points.
2025-10-19 11:44:20